Institutional Investors Are Trading These Shares in the Healthcare Sector

Wall St. Watchdog reveals information about institutional trading in the Healthcare sector.  The higher the ratio of net trades to total shares outstanding, the greater the influence of institutional trading on a particular company’s stock price. Institutional investors are trading these Healthcare stocks now:

  • Johnson + Johnson (NYSE:JNJ): Institutional investors bought 114,060,360 shares and sold 89,179,200 shares, for a net of 24,881,160 shares. This net represents 0.90% of common shares outstanding. The number of shares outstanding is 2,751,400,000. The shares recently traded at $64.28 and the company’s market capitalization is $176,150,000,000.00. About the company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Novartis AG (ADR) (NYSE:NVS): Institutional investors bought 32,802,900 shares and sold 21,280,930 shares, for a net of 11,521,970 shares. This net represents 0.50% of common shares outstanding. The number of shares outstanding is 2,286,000,000. The shares recently traded at $56.59 and the company’s market capitalization is $157,921,800,000.00. About the company: Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases; oncology, neuroscience, transplantation, dermatology, gastrointestinal and urinary conditions, and arthritis; vaccines and diagnostics; vision, and animal health products.
  • Pfizer Inc. (NYSE:PFE): Institutional investors bought 319,021,940 shares and sold 387,183,670 shares, for a net of -68,161,730 shares. This net represents 0.85% of common shares outstanding. The number of shares outstanding is 8,036,000,000. The shares recently traded at $18.21 and the company’s market capitalization is $142,076,700,000.00. About the company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • GlaxoSmithKline plc (ADR) (NYSE:GSK): Institutional investors bought 21,484,930 shares and sold 9,263,850 shares, for a net of 12,221,080 shares. This net represents 0.24% of common shares outstanding. The number of shares outstanding is 5,085,000,000. The shares recently traded at $41.64 and the company’s market capitalization is $105,950,280,262.99. About the company: GlaxoSmithKline plc is a research-based pharmaceutical group that develops, manufactures and markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer products. The Group, which also provides laboratory testing and disease management services, specializes in treatments for respiratory, central nervous system, gastro-intestinal and genetic disorders.
  • Merck + Co., Inc. (NYSE:MRK): Institutional investors bought 143,902,620 shares and sold 113,861,730 shares, for a net of 30,040,890 shares. This net represents 0.97% of common shares outstanding. The number of shares outstanding is 3,095,000,000. The shares recently traded at $31.92 and the company’s market capitalization is $98,339,040,000.00. About the company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Sanofi SA (ADR) (NYSE:SNY): Institutional investors bought 38,820,600 shares and sold 14,793,700 shares, for a net of 24,026,900 shares. This net represents 1.84% of common shares outstanding. The number of shares outstanding is 1,305,300,000. The shares recently traded at $35.53 and the company’s market capitalization is $94,959,895,796.99. About the company: Sanofi-Aventis is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.
  • Abbott Laboratories (NYSE:ABT): Institutional investors bought 61,952,440 shares and sold 64,752,780 shares, for a net of -2,800,340 shares. This net represents 0.18% of common shares outstanding. The number of shares outstanding is 1,546,400,000. The shares recently traded at $50.15 and the company’s market capitalization is $78,062,310,000.00. About the company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • AstraZeneca plc (ADR) (NYSE:AZN): Institutional investors bought 10,056,110 shares and sold 20,116,350 shares, for a net of -10,060,240 shares. This net represents 0.70% of common shares outstanding. The number of shares outstanding is 1,438,000,000. The shares recently traded at $45.96 and the company’s market capitalization is $61,686,010,000.00. About the company: AstraZeneca PLC is a holding company. Through its subsidiaries, the Group researches, manufactures and sells pharmaceutical and medical products. The Group focuses its operations on seven therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia and Infection.
  • Amgen, Inc. (NASDAQ:AMGN): Institutional investors bought 60,108,660 shares and sold 55,360,490 shares, for a net of 4,748,170 shares. This net represents 0.49% of common shares outstanding. The number of shares outstanding is 960,000,000. The shares recently traded at $54.08 and the company’s market capitalization is $49,974,860,000.00. About the company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Bristol Myers Squibb Co. (NYSE:BMY): Institutional investors bought 85,426,260 shares and sold 79,073,730 shares, for a net of 6,352,530 shares. This net represents 0.37% of common shares outstanding. The number of shares outstanding is 1,713,000,000. The shares recently traded at $28.72 and the company’s market capitalization is $48,986,750,000.00. About the company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.

(Note: Selected financial data are sourced from screener.co.  All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>